- EP4 receptor agonists: the most promising novel bronchodilator for several decades
Buckley J, Birrell M, Maher S, Nials A, Clarke D, Belvisi M
- Erythropoietin Attenuates Cardiac Dysfunction Caused by Endotoxaemia in Mice
Khan A, Coldewey S, Shintani Yi, Suzuki K, Patel N, Thiemermann C
- Estimation of protein binding affinities of IP receptor ligands using a radioligand receptor binding assay
Ensor P, Sykes D, Blakeley D, Bauer C, Charlton S
- Evaluation Of The Human Platelet Response in vivo Using A NOD-scid Mouse Model
Holbrook LM, Moore Cr, Emerson M
- Evidence For 5-HT7 Receptor Mediated Contraction Of The Isolated Rat Detrusor Muscle
Kleu L, James L, Hughes E, Liang S, Makda Z, Bailey S
- Evidence for an anti-inflammatory loop centred on PMN FPR2/ALX and operative in the inflamed microvasculature
Brancaleone V, Bena S, Dalli J, Flower RJ, Cirino G, Perretti M
- Fatty Acid Amide Hydrolase And Monoacylglycerol Lipase Activities In Adipocytes Taken From Obese Surgical Patients
Cable J, Tan G, Alexander S, O Sullivan S
- Fpr2/ALX is a Potential Therapeutic Target for the Treatment of Sepsis
Hughes E, Buckingham J, Gavins F
- Functional Activity of Apelin Peptides in Human Saphenous Vein
Brame A, Maguire J, Kuc R, Davenport A
- Functional activity of novel Y2/Y4 receptor agonists for the treatment of obesity
Jolly N, Elling C, Little P, Gerlach LO, Schwartz T, Cox H